Integrated Research Limited provided revenue guidance for the full year 2023. Subject to audit, the company expected the TCV result to translate into reported statutory revenue in the range of $39 million - $42 million for the period, an increase of 1% - 9% on the pcp. On a pro-forma basis, revenue is anticipated to be in the range of $36 million - $38 million, down -6% - 0% on the pcp, reflecting lower recurring (licence) revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 AUD | 0.00% | +13.16% | +19.44% |
Mar. 06 | Cathy Aston Resigns as Director of Integrated Research Limited, Effective 31 March 2024 | CI |
Feb. 22 | Transcript : Integrated Research Limited, H1 2024 Earnings Call, Feb 22, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.44% | 49.25M | |
+6.97% | 2,990B | |
+5.80% | 83.1B | |
+3.72% | 76.88B | |
-16.11% | 52.88B | |
+32.96% | 50.84B | |
-25.56% | 46.09B | |
+17.43% | 41.3B | |
+59.31% | 37.06B | |
-10.36% | 24.61B |
- Stock Market
- Equities
- IRI Stock
- News Integrated Research Limited
- Integrated Research Limited Provides Revenue Guidance for the Full Year 2023